SynthesisCurrent diabetes reviews2026
Discovering New Challenges in the Pharmacological and Non-Pharmacological Management of Insulin Resistance.
Synthesis in Current diabetes reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInsulin resistance has become a serious health problem over time. As people age, the incidence of insulin resistance increases. Genetic factors in families with a history of type 2 diabetes are also key risk factors. In Indonesia, an increase in the prevalence of type 2 diabetes to 8.5% was reported in 2018. This indicates that insulin resistance necessitates comprehensive management, encompassing both pharmacological and non-pharmacological approaches. This systematic review aims to discuss insulin resistance and its management, which can be achieved both pharmacologically through various available drugs and non-pharmacologically by modifying lifestyle habits that can be applied to patients with type 2 diabetes.
methodStudies examining the comprehensive management of insulin resistance with antidiabetic pharmacological drugs and non-pharmaceutical interventions published between 2018 and 2023 were comprehensively searched using advanced searches on PubMed and Google Scholar, according to the specified inclusion and exclusion criteria.
resultsTwenty studies were selected that met the inclusion criteria and have low risks of bias in most domains. DISCUSSION: Non-pharmacological therapy, such as lifestyle changes that include a ketogenic diet, a vegetarian diet, a structured exercise intervention program, aerobic exercise, Continuous Positive Airway Pressure (CPAP), and electroacupuncture therapy, can significantly reduce insulin resistance and increase insulin sensitivity. Drugs currently prescribed for type 2 DM stimulate insulin secretion or increase insulin sensitivity.
conclusionThere are benefits of a plant-based diet, a ketogenic diet, and physical exercise in reducing insulin resistance non-pharmacologically. Meanwhile, pharmacologically, the first drug often given is metformin monotherapy. Combination therapy may be considered if monotherapy does not achieve the therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.